MindWalk Holdings Corp. (HYFT) vs Spero Therapeutics, Inc. (SPRO)
- MindWalk Holdings Corp. HYFT 1.31 −6.43%
- Spero Therapeutics, Inc. SPRO 1.10 −2.65%
MindWalk Holdings Corp. and Spero Therapeutics, Inc. are both Biotechnology companies. MindWalk Holdings Corp. and Spero Therapeutics, Inc. are of similar size ($66.0M and $65.8M). MindWalk Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 7.9×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against −27.0%. Spero Therapeutics, Inc. has the higher net margin (0.00% vs −105.1%) and the higher return on invested capital (0.00% vs −464.6%). Across the 18 metrics below, Spero Therapeutics, Inc. leads on 18 and MindWalk Holdings Corp. on 0.
Valuation
Profitability
| Metric | HYFT | SPRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 60.81% | 100.00% | 65.16% |
| Operating margin | (103.99%) | 0.00% | 0.00% |
| Net margin | (105.06%) | 0.00% | 0.00% |
| Free cash flow margin | (76.79%) | 0.00% | 0.00% |
| Return on equity | (122.85%) | 19.17% | (56.36%) |
| Return on assets | (58.55%) | 12.85% | (48.04%) |
| Return on invested capital | (464.59%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack